Cargando…

Albuminuria during treatment with angiotensin type II receptor blocker is a predictor for GFR decline among non-diabetic hypertensive CKD patients

BACKGROUND: Albuminuria is a predictor of disease progression in patients with chronic kidney disease (CKD). However, the ability of proteinuria parameters measured at various time periods to predict renal outcomes is unclear. METHOD: This observational cohort study included 165 non-diabetic hyperte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Mi-Yeon, Kim, Dong Ki, Park, Jung Hwan, Shin, Sung Joon, Lee, Sang Ho, Choi, Bum Soon, Lim, Chun Soo, Chin, Ho Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6110474/ https://www.ncbi.nlm.nih.gov/pubmed/30148871 http://dx.doi.org/10.1371/journal.pone.0202676

Ejemplares similares

The Decrement of Hemoglobin Concentration with Angiotensin II Receptor Blocker Treatment Is Correlated with the Reduction of Albuminuria in Non-Diabetic Hypertensive Patients: Post-Hoc Analysis of ESPECIAL Trial
por: An, Jung Nam, et al.
Publicado: (2015)

Urinary Markers of Oxidative Stress Are Associated With Albuminuria But Not GFR Decline
por: Schei, Jørgen, et al.
Publicado: (2017)

Combined Albuminuria and Estimated GFR Laboratory Reporting Affects Primary Care Management of CKD
por: Vassalotti, Joseph A., et al.
Publicado: (2020)

Dapagliflozin reduces albuminuria in patients with diabetes and hypertension receiving renin‐angiotensin blockers
por: Heerspink, H. J. L., et al.
Publicado: (2016)

Mild Albuminuria Is a Risk Factor for Faster GFR Decline in the Nondiabetic Population
por: Melsom, Toralf, et al.
Publicado: (2018)

Weight loss has an additive effect on the proteinuria reduction of angiotensin II receptor blockers in hypertensive patients with chronic kidney disease
por: Ahn, Shin Young, et al.
Publicado: (2018)

Time-dependent risk factors associated with the decline of estimated GFR in CKD patients
por: Chang, Wen-xiu, et al.
Publicado: (2015)

Clinical Value of NGAL, L-FABP and Albuminuria in Predicting GFR Decline in Type 2 Diabetes Mellitus Patients
por: Chou, Kuei-Mei, et al.
Publicado: (2013)

Urinary adiponectin and albuminuria in non-diabetic hypertensive patients: an analysis of the ESPECIAL trial
por: Han, Seung Seok, et al.
Publicado: (2015)

Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study
por: Gunzler, Douglas, et al.
Publicado: (2013)

Impact of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers on clinical outcomes in hypertensive patients with acute myocardial infarction
por: Lee, Jae-Geun, et al.
Publicado: (2023)

Population Estimates of GFR and Risk Factors for CKD in Guatemala
por: Miller, Ann C., et al.
Publicado: (2021)

Effects of adding tripterygium glycosides to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on albuminuria in patients with diabetic nephropathy
por: Fang, Jin-Ying, et al.
Publicado: (2020)

How to Assess Diabetic Kidney Disease Progression? From Albuminuria to GFR
por: García-Carro, Clara, et al.
Publicado: (2021)

Investigation of Metabolic Factors Associated with eGFR Decline Over 1 Year in a Japanese Population without CKD
por: Hayashi, Kaori, et al.
Publicado: (2017)

Degree of Albuminuria is Associated With Increased Risk of Fragility Fractures Independent of Estimated GFR
por: Cooke-Hubley, Sandra M., et al.
Publicado: (2023)

Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial
por: Uzu, Takashi, et al.
Publicado: (2016)

Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
por: Lee, Hyun Woong
Publicado: (2014)

Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study
por: Kim, Ju Hwan, et al.
Publicado: (2020)

Performance of the race-free CKD-EPI creatinine-based eGFR equation in a Danish cohort with measured GFR
por: Munch, Philip Vestergaard, et al.
Publicado: (2023)

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension
por: Bisognano, John D, et al.
Publicado: (2007)

High rates of albuminuria but not of low eGFR in Urban Indigenous Australians: the DRUID Study
por: Maple-Brown, Louise J, et al.
Publicado: (2011)

Estimated GFR, Albuminuria, and Physical Function: The Brain in Kidney Disease (BRINK) Cohort Study
por: Mello, Ryan, et al.
Publicado: (2022)

Differential correlation between time in range and eGFR or albuminuria in type 2 diabetes
por: Jin, Xuguang, et al.
Publicado: (2023)

Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients
por: Kim, Eun Seok, et al.
Publicado: (2013)

Urinary Sodium Excretion Has Positive Correlation with Activation of Urinary Renin Angiotensin System and Reactive Oxygen Species in Hypertensive Chronic Kidney Disease
por: Ahn, Shin-Young, et al.
Publicado: (2014)

Higher medical costs for CKD patients with a rapid decline in eGFR: A cohort study from the Japanese general population
por: Nagai, Kei, et al.
Publicado: (2019)

Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation
por: Park, Jeong-Hwan, et al.
Publicado: (2009)

ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death
por: Arora, Nayan, et al.
Publicado: (2020)

Diminished antiproteinuric effect of the angiotensin receptor blocker losartan during high potassium intake in patients with CKD
por: Wouda, Rosa D, et al.
Publicado: (2021)

Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults
por: Seliger, Stephen L., et al.
Publicado: (2016)

Efficacy and safety of azilsartan medoxomil, an angiotensin receptor blocker, in Korean patients with essential hypertension
por: Juhasz, Attila, et al.
Publicado: (2018)

Clinic and Home Blood Pressure Lowering Effect of an Angiotensin Receptor Blocker, Fimasartan, in Postmenopausal Women with Hypertension
por: Kim, Song-Yi, et al.
Publicado: (2016)

Association of eGFR-Related Loci Identified by GWAS with Incident CKD and ESRD
por: Böger, Carsten A., et al.
Publicado: (2011)

Accuracy of freely available online GFR calculators using the CKD-EPI equation
por: Seiberth, Sarah, et al.
Publicado: (2020)

Classification of Kidney Transplant Recipients Using a Combination of Estimated GFR and Albuminuria Reflects Risk
por: White, Christine A., et al.
Publicado: (2016)

Associations between eGFR and albuminuria with right ventricular measures: the MESA-Right Ventricle study
por: Husain-Syed, Faeq, et al.
Publicado: (2023)

Impact of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) GFR Estimating Equations on CKD Prevalence and Classification Among Asians
por: Betzler, Bjorn Kaijun, et al.
Publicado: (2022)

Clinical outcomes between calcium channel blockers and angiotensin receptor blockers in hypertensive patients without established cardiovascular diseases during a 3-year follow-up
por: Jeong, Han Saem, et al.
Publicado: (2021)

Albuminuria but not low eGFR is closely associated with atherosclerosis in patients with type 2 diabetes: an observational study
por: Wang, Jun-Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m1n0nmvp2dmjuavd83gn5qe3rn